• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醋酸亮丙瑞林治疗对子宫肌瘤组织病理学的评估。

Evaluation of leuprolide acetate treatment on histopathology of uterine myomata.

作者信息

Gutmann J N, Thornton K L, Diamond M P, Carcangiu M L

机构信息

Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut.

出版信息

Fertil Steril. 1994 Apr;61(4):622-6.

PMID:8150102
Abstract

OBJECTIVE

To determine if short-term, preoperative leuprolide acetate (LA) therapy alters the histologic appearance of uterine leiomyomata.

DESIGN

Retrospective evaluation by a pathologist (who was blinded to patient history) of the histologic features of leiomyomata excised from 36 women, 12 who received preoperative LA and 24 age-matched controls.

SETTING

Yale-New Haven Hospital, New Haven, Connecticut, from September 1989 to September 1990.

MAIN OUTCOME MEASURE

The histologic specimens were evaluated for the presence of mitotic activity, cellular atypia, cellularity, and secondary changes including edema, fibrosis, calcification, hemorrhage, infarction, hyalinization, and vascular appearance.

RESULTS

Of the 12 patients treated with LA, 10 (84%) demonstrated a reduction in uterine volume after 3 to 6 months of LA therapy. There was no difference in any of the histopathologic parameters evaluated between the LA-treated group and the untreated group. Exclusion of leiomyoma, which did not have a reduction in size during LA therapy, did not alter the analysis. Among patients treated with LA, those leiomyoma that did not respond to LA had a greater degree of hyalinization than those that responded.

CONCLUSION

Reduction in uterine size by short-term LA therapy did not detectably alter histologic appearance of leiomyoma.

摘要

目的

确定术前短期使用醋酸亮丙瑞林(LA)治疗是否会改变子宫平滑肌瘤的组织学外观。

设计

由一名病理学家(对患者病史不知情)对36名女性切除的平滑肌瘤的组织学特征进行回顾性评估,其中12名接受术前LA治疗,24名年龄匹配的对照者。

地点

1989年9月至1990年9月,康涅狄格州纽黑文市的耶鲁-纽黑文医院。

主要观察指标

评估组织学标本中是否存在有丝分裂活性、细胞异型性、细胞密度以及包括水肿、纤维化、钙化、出血、梗死、透明变性和血管外观在内的继发性改变。

结果

在接受LA治疗的12名患者中,10名(84%)在LA治疗3至6个月后子宫体积减小。LA治疗组和未治疗组之间评估的任何组织病理学参数均无差异。排除LA治疗期间体积未减小的平滑肌瘤,并未改变分析结果。在接受LA治疗的患者中,对LA无反应的平滑肌瘤比有反应的平滑肌瘤透明变性程度更高。

结论

短期LA治疗使子宫体积减小并未显著改变平滑肌瘤的组织学外观。

相似文献

1
Evaluation of leuprolide acetate treatment on histopathology of uterine myomata.醋酸亮丙瑞林治疗对子宫肌瘤组织病理学的评估。
Fertil Steril. 1994 Apr;61(4):622-6.
2
Histology of leiomyomata in patients treated with leuprolide acetate.接受醋酸亮丙瑞林治疗患者的平滑肌瘤组织学
Int J Gynecol Pathol. 1997 Apr;16(2):131-7. doi: 10.1097/00004347-199704000-00008.
3
Histopathologic findings in 107 uterine leiomyomas treated with leuprolide acetate compared with 126 controls.将107例接受醋酸亮丙瑞林治疗的子宫平滑肌瘤的组织病理学结果与126例对照进行比较。
Am J Surg Pathol. 1996 Apr;20(4):427-32. doi: 10.1097/00000478-199604000-00005.
4
Absence of a dose-response effect of leuprolide acetate on leiomyomata uteri size.醋酸亮丙瑞林对子宫肌瘤大小不存在剂量反应效应。
Fertil Steril. 1994 Jun;61(6):1021-6.
5
Hyalinization and cellular changes in uterine leiomyomata after gonadotropin releasing hormone agonist therapy.
J Reprod Med. 1994 May;39(5):377-80.
6
Histopathological changes in leiomyomata treated with leuprolide acetate.醋酸亮丙瑞林治疗的平滑肌瘤的组织病理学变化。
Fertil Steril. 1990 Nov;54(5):811-4. doi: 10.1016/s0015-0282(16)53937-5.
7
Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist.促性腺激素释放激素激动剂治疗的子宫肌瘤女性子宫体积缩小的预测因素
Fertil Steril. 1992 Aug;58(2):413-5.
8
Pathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomata.促性腺激素释放激素激动剂类似物治疗子宫平滑肌瘤的病理变化
Fertil Steril. 1997 May;67(5):837-41. doi: 10.1016/s0015-0282(97)81394-5.
9
Massive ascites after leuprolide acetate administration for the treatment of leiomyomata uteri.
Fertil Steril. 1992 Aug;58(2):416-8. doi: 10.1016/s0015-0282(16)55233-9.
10
Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas.GnRH 激动剂治疗的子宫平滑肌瘤中的细胞增殖、雌激素受体、孕激素受体及 bcl-2 表达
Hum Pathol. 1998 Apr;29(4):359-63. doi: 10.1016/s0046-8177(98)90116-2.